Furthermore, in various tumors, including lung cancer, breast cancer, and colorectal cancer, the activation of the CXCL12/CXCR4/ACKR3 signaling axis has been associated with STAT3 pathway activation [49,50,51,52]. This evidence concerns the gene CXCL12 and breast carcinoma.